Pamicell Rises 18.32% on COVID-19 (Remdesivir) Theme Uptrend

On the 23rd, the COVID-19 (Remdesivir) theme showed a strong performance, rising 8.90% compared to the previous day, while Pharmicell, a related stock drawing attention, surged 18.32% compared to the previous day. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Pharmicell ranked 2nd out of 4 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Pharmicell having a relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.